Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape
Janakiraman Subramanian,1 Jamie Cavenagh,2 Bhardwaj Desai,3 Ira Jacobs4 1Division of Medical Oncology, Saint Luke’s Cancer Institute, Kansas City, MO, USA; 2Department of Haematology, St.Bartholomew’s Hospital, London, UK; 3Prospect Heights, IL, 4Global Established Pharma, copyright Inc., New York, NY, USA Abstract: Follicular lymp